Depressive Disorder, Major: all 2,805 studies
Page 16 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.
- Pilot Study of a Brief Behavioural Activation Intervention for Depressed Patients in Primary CareTerminatedNCT05273983Not applicable
- Transcranial Magnetic Stimulation for Depression in Autism Spectrum ConditionsCompletedNCT05271357Not applicable
- Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive DisorderCompletedNCT05271084Phase 1/2
- Combining Data Sources to Identify Effect Moderation for Personalized Mental HealthCompletedNCT05267873
- Pre-mapping Networks for Brain Stimulation 2CompletedNCT05260086Not applicable
- Microdosing Psychedelics to Improve MoodCompletedNCT05259943Phase 2
- Clinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory ComplaintsCompletedNCT05257902Not applicable
- Naturalistic Study of Ketamine in the Treatment of DepressionActive, not recruitingNCT05249309
- Medication Reviews in Severe Mental IllnessCompletedNCT05243160Not applicable
- Invasive Decoding and Stimulation of Altered Reward Computations in Depression PatientsCompletedNCT05239780Not applicable
- Mindfulness-Based Cognitive Therapy for Depressed IAPT Non-RespondersStatus unknownNCT05236959Not applicable
- Neural Mechanisms of Intermittent Theta Burst Stimulation in the Core Depression NetworkActive, not recruitingNCT05224206Not applicable
- The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal IdeationCompletedNCT05220410Phase 2
- RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood TraumaCompletedNCT05217758Phase 2
- Using Repetitive Transcranial Magnetic Stimulation to Study the Role of Frontostriatal Circuit in Major Depressive DisorderCompletedNCT05212636Not applicable
- Personalized Sertraline Dosing in Patients With DepressionWithdrawnNCT05210153
- Personalized Escitalopram Dosing in Patients With DepressionStatus unknownNCT05210140
- Home-based Transcranial Direct Current Stimulation (tDCS) for Major Depressive Disorders (MDD)Status unknownNCT05205915Not applicable
- Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)CompletedNCT05203341Phase 2
- A Study of HS-10353 in Chinese Participants.CompletedNCT05195203Phase 1
- Transcranial Low Intensity Focused Ultrasound Neuromodulation as a Probe to Study Human Emotion and Cognitive FunctionWithdrawnNCT05194332Not applicable
- Using Electrophysiology to Index Non-invasive Brain Stimulation Effects on Reward System Functioning in DepressionCompletedNCT05194098Not applicable
- Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT05181527Phase 4
- Neurocognitive Effects of FMT in MDD Patients With and Without IBSActive, not recruitingNCT05174273Phase 2/3
- Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD)Active, not recruitingNCT05172271Not applicable
- ALTO-300 in Depression (ALTO-300-004)CompletedNCT05157945Phase 2
- RESET-psychotherapy: the Effectiveness of Trauma-focused Therapy in Patients With Depression and Childhood TraumaStatus unknownNCT05149352Not applicable
- A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive DisorderStatus unknownNCT05148169Phase 4
- Pilot Study: Investigating Mood Changes After Slow-wave EnhancementWithdrawnNCT05146427Not applicable
- A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial TreatmentStatus unknownNCT05145270Phase 4
- Effects of Electroacupuncture With Different Frequencies for Major Depressive DisorderStatus unknownNCT05144880Not applicable
- Confirm the Effectiveness of Predictix Genetics Antidepressant -Guided Treatment in Adults With MDDStatus unknownNCT05137197Not applicable
- A Study of Xiongdan Wan Treating DepressionCompletedNCT05136365Phase 2
- Mindbeacon Therapist Assisted Internet Delivered CBT for DepressionWithdrawnNCT05134103Not applicable
- Treatment of Major Depression by rTMS on Dorsolateral Prefrontal Cortex: Study of Underlying MechanismsStatus unknownNCT05121129Not applicable
- tVNS Effects on Motivation in DepressionCompletedNCT05120336Not applicable
- ALTO-300 in DepressionCompletedNCT05118750Phase 2
- ALTO-100 in MDD and/or PTSDCompletedNCT05117632Phase 2
- Decentering and Relapse/Recurrence in MBCT for Depression in AdultsCompletedNCT05111665Not applicable
- A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor AntidepressantTerminatedNCT05109195
- Individual MBCT vs. CBT in Major Depression: A Pilot Study.CompletedNCT05108701Not applicable
- Acupuncture for Patients With Major Depressive DisorderStatus unknownNCT05106868Not applicable
- Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive AbilitiesStatus unknownNCT05104918Phase 3
- Rapid Acting TMS for Suicide Ideation in DepressionWithdrawnNCT05100004Not applicable
- A Remote Electronically Delivered Integrated Care Pathway: A Feasibility StudyTerminatedNCT05086120Not applicable
- OMT as an Adjunctive Treatment in MDDCompletedNCT05065580Not applicable
- Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority StudyCompletedNCT05054699Phase 2/3
- The Role of Neuromodulation Technique In Depression DisorderStatus unknownNCT05047159Not applicable
- Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant DepressionCompletedNCT05045378Phase 4
- Cannabinoids as a Treatment for Insomnia in Major DepressionCompletedNCT05041647Phase 2
- The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder PatientsWithdrawnNCT05030623Phase 1/2
- Patient-oriented Randomized Pragmatic Feasibility Trial With rTMS in Depression and AnxietyActive, not recruitingNCT05028738Not applicable
- Assessing the Impact of Electroacupuncture on Facial Thermal Characteristics of Major Depressive Disorder Patients Based on Infrared Thermal Imaging TechnologyStatus unknownNCT05024149Not applicable
- Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With DepressionStatus unknownNCT05018013Phase 2
- Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)CompletedNCT05016050Not applicable
- Sevoflurane for Treatment-Resistant DepressionStatus unknownNCT05008939Not applicable
- EffectsOfTranscranialPulseStimulationOnDepression-PilotRCTCompletedNCT05006365Not applicable
- Web-based Self-help Intervention for Adolescents With Acute or Remitted Major Depressive DisorderCompletedNCT04994470Not applicable
- Quality of Life in Chinese Working and School Age Population With MDDStatus unknownNCT04986124
- Safety and Tolerability of Zelquistinel in Normal Human VolunteersCompletedNCT04981561Phase 1
- Efficacy and Cost-effectiveness of Internet-delivered CBT for Adolescents With DepressionCompletedNCT04977856Not applicable
- Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive DisorderCompletedNCT04975100Phase 4
- Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast CancerSuspendedNCT04973930Phase 3
- Exploring Engagement With Remote Symptom Tracking for Depression (RADAR: Engage)Status unknownNCT04972474Not applicable
- An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent PatientsStatus unknownNCT04971291Phase 2
- A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive DisorderCompletedNCT04969510Phase 2
- Alpha-Stim AID and Major Depressive DisorderStatus unknownNCT04963907Not applicable
- Sustained Mood Improvement With Laughing Gas Exposure: A Randomized Controlled Pilot TrialCompletedNCT04957368Phase 4
- A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and PsychotherapyTerminatedNCT04951609Phase 1
- Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric DisordersCompletedNCT04939818
- Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse StudyCompletedNCT04933630
- ECT vs. EsketamineWithdrawnNCT04924257Phase 3
- Can the Affects Conveyed by Baroque Music Reduce Anxiety in Patients With Major Depressive Disorder ?CompletedNCT04903522Not applicable
- Effects of Vitamin D Supplementation on Depression and Inflammatory MarkersCompletedNCT04898725Not applicable
- Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in VeteransWithdrawnNCT04893395Not applicable
- Portable Transcranial Electrical Stimulation and Internet-Based Behavioral Therapy for Major Depression StudyCompletedNCT04889976Not applicable
- SSIPP vs. PST vs. WLCWithdrawnNCT04887350Phase 1
- Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder PatientsCompletedNCT04880460Phase 2
- Feasibility of a Novel Process-based Treatment for Patients With PsychosisCompletedNCT04874974Not applicable
- Using Voice Biomarkers to Predict the Likelihood of Major Depressive DisorderCompletedNCT04874077
- Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive DisorderCompletedNCT04864353Not applicable
- A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedNCT04853407Phase 3
- Reward Emotion Learning and Ketamine StudyStatus unknownNCT04850911Not applicable
- Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive DisorderStatus unknownNCT04847245Not applicable
- Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)Active, not recruitingNCT04846829Early Phase 1
- Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine SprayStatus unknownNCT04843462Not applicable
- Magnetic Randomized Trial in Elderly DepressedCompletedNCT04842929Not applicable
- MAO-B Occupancy in Depressed PatientsCompletedNCT04841798Not applicable
- Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on SleepCompletedNCT04832750
- A Clinical Trial of PRAX-114 in Participants With Major Depressive DisorderCompletedNCT04832425Phase 2/3
- A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric EmergencyWithdrawnNCT04829669
- Clonidine to Prevent Delirium After Electroconvulsive Therapy.CompletedNCT04828226Phase 4
- XEN1101 for Major Depressive DisorderCompletedNCT04827901Phase 2
- Comparing Efficacy of Optimal Treatment and Conventional Treatment for Major Depressive Disorder in Viet NamCompletedNCT04826614Not applicable
- Non-Inferiority RCT Comparing Online and On-Site CBT in MDDiWithdrawnNCT04825535Not applicable
- Ketamine IV Classic Protocol : Five Years Follow upCompletedNCT04824157
- The Effect of Celecoxib on Neuroinflammation in MDDCompletedNCT04814355Phase 4
- rTMS for Suicidality in Opioid Use DisorderCompletedNCT04785456Not applicable
- MST for Parkinson's DiseaseActive, not recruitingNCT04784494Not applicable
- Internet-delivered Cognitive Behavioral Treatment of Depression and Anxiety in Latin American College StudentsActive, not recruitingNCT04780542Not applicable